Subtopic Deep Dive
Fibrinogen in Hemostasis
Research Guide
What is Fibrinogen in Hemostasis?
Fibrinogen in hemostasis examines fibrinogen's central role in platelet aggregation, fibrin clot formation, and its modulation by polymorphisms, dysfibrinogenemias, and acute phase responses.
Fibrinogen binds to activated platelet GPIIb/IIIa receptors exposed by ADP and epinephrine (Bennett et al., 1979, 855 citations). Elevated fibrinogen levels predict myocardial infarction risk in angina patients (Thompson et al., 1995, 1798 citations). Dysfibrinogenemia and fibrin split products influence clot stability and fibrinolysis (Merskey et al., 1966, 479 citations). Over 10 key papers span platelet binding to clinical risk factors.
Why It Matters
Fibrinogen levels independently predict acute coronary events, guiding antithrombotic therapies in angina patients (Thompson et al., 1995). Platelet fibrinogen receptor exposure drives aggregation essential for hemostasis (Bennett et al., 1979). Fibrin split products from fibrinolysis diagnose defibrination syndromes, informing hemorrhage treatments (Merskey et al., 1966). Acute phase fibrinogen rises link inflammation to thrombosis risk (Pepys et al., 2003). These insights target fibrinogen as a modifiable factor in thrombotic diseases.
Key Research Challenges
Quantifying dysfibrinogenemia effects
Dysfibrinogenemias alter clot structure but quantifying functional impact on hemostasis remains difficult. Methods like Laurell rocket assays detect protein C deficiencies but struggle with fibrinogen variants (Griffin et al., 1981). Over 500 citations highlight inconsistent lysis assays across studies.
Linking fibrinogen to thrombosis risk
Elevated fibrinogen predicts infarction but causality versus correlation is unresolved (Thompson et al., 1995). Acute phase responses confound levels during inflammation (Pepys et al., 2003). Prospective cohorts with 1798 citations show low fibrinogen protects but mechanisms need clarification.
Modeling platelet-fibrinogen binding
ADP exposes fibrinogen receptors on platelets but dynamic binding kinetics vary (Bennett et al., 1979). FXIII crosslinking stabilizes clots yet polymorphisms disrupt this (Laurens et al., 2006). Assays using 125I-fibrinogen quantify binding but lack in vivo validation.
Essential Papers
C-reactive protein: a critical update
Mark B. Pepys, Gideon M. Hirschfield · 2003 · Journal of Clinical Investigation · 3.3K citations
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
Simon G. Thompson, Joachim Kienast, Stephen Pyke et al. · 1995 · New England Journal of Medicine · 1.8K citations
In patients with angina pectoris, the levels of fibrinogen, von Willebrand factor antigen, and t-PA antigen are independent predictors of subsequent acute coronary syndromes. In addition, low fibri...
Deficiency of protein C in congenital thrombotic disease.
John H. Griffin, B. L. Evatt, T S Zimmerman et al. · 1981 · Journal of Clinical Investigation · 1.3K citations
A family with a history of recurring thrombosis was studied to determine if a plasma protein deficiency could account for the observed disease. Protein C levels in plasma were determined immunologi...
Exposure of platelet fibrinogen receptors by ADP and epinephrine.
Joel Bennett, Gaston Vilaire · 1979 · Journal of Clinical Investigation · 855 citations
The role of fibrinogen as a cofactor for platelet aggregation was examined by measuring the binding of 125I-labeled human fibrinogen to gel-filtered human platelets both before and after platelet s...
Fibrinolysis and the control of blood coagulation
John Chapin, Katherine A. Hajjar · 2014 · Blood Reviews · 795 citations
Fibrin structure and wound healing
Niels Laurens, Pieter Koolwijk, Moniek P.M. de Maat · 2006 · Journal of Thrombosis and Haemostasis · 690 citations
Platelets and Thrombin Generation
Dougald M. Monroe, Maureane Hoffman, Harold R. Roberts · 2002 · Arteriosclerosis Thrombosis and Vascular Biology · 669 citations
This review examines the evidence that platelets play a major role in localizing and controlling the burst of thrombin generation leading to fibrin clot formation. From the first functional descrip...
Reading Guide
Foundational Papers
Start with Bennett et al. (1979) for platelet fibrinogen binding basics, then Thompson et al. (1995) for clinical risk data, and Pepys et al. (2003) for acute phase context; these 5000+ citations establish core mechanisms.
Recent Advances
Chapin et al. (2014) reviews fibrinolysis control; Laurens et al. (2006) details fibrin structure; both build on platelet roles from Jurk et al. (2005).
Core Methods
125I-labeling for binding (Bennett et al., 1979); cohort risk analysis (Thompson et al., 1995); rocket immunoassays (Griffin et al., 1981); split product quantitation (Merskey et al., 1966).
How PapersFlow Helps You Research Fibrinogen in Hemostasis
Discover & Search
Research Agent uses searchPapers with 'fibrinogen hemostasis dysfibrinogenemia' to retrieve Thompson et al. (1995) and 50+ related papers from 250M+ OpenAlex corpus. citationGraph maps high-citation clusters from Bennett et al. (1979) to Pepys et al. (2003), revealing acute phase links. exaSearch uncovers polymorphism studies; findSimilarPapers expands from Merskey et al. (1966) on split products.
Analyze & Verify
Analysis Agent applies readPaperContent to extract fibrinogen binding data from Bennett et al. (1979), then runPythonAnalysis with NumPy/pandas to model receptor exposure kinetics from raw assay values. verifyResponse via CoVe cross-checks claims against Thompson et al. (1995) cohort data. GRADE grading scores evidence strength for risk prediction, verifying low fibrinogen's protective role statistically.
Synthesize & Write
Synthesis Agent detects gaps in dysfibrinogenemia crosslinking via contradiction flagging between Laurens et al. (2006) and Griffin et al. (1981). Writing Agent uses latexEditText to draft equations for clot formation, latexSyncCitations to integrate 10 papers, and latexCompile for publication-ready review. exportMermaid generates flowcharts of platelet-fibrinogen-thrombin pathways.
Use Cases
"Analyze fibrinogen binding kinetics from platelet assays in hemostasis papers"
Research Agent → searchPapers('fibrinogen platelet binding') → Analysis Agent → readPaperContent(Bennett 1979) → runPythonAnalysis(pandas plot of 125I-fibrinogen binding curves) → matplotlib graph of ADP/epinephrine effects.
"Write LaTeX review on fibrinogen's role in coronary risk"
Synthesis Agent → gap detection(Thompson 1995 + Pepys 2003) → Writing Agent → latexEditText(structure sections) → latexSyncCitations(10 papers) → latexCompile(PDF with fibrin clot diagram via latexGenerateFigure).
"Find code for simulating fibrin clot formation models"
Research Agent → searchPapers('fibrinogen clot simulation') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect(pull NumPy thrombin generation code from Monroe 2002-inspired repos) → runPythonAnalysis(test clot stability).
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ fibrinogen hemostasis papers) → citationGraph → GRADE all claims → structured report on polymorphisms. DeepScan applies 7-step analysis with CoVe checkpoints to verify Thompson et al. (1995) risk factors against Bennett et al. (1979) mechanisms. Theorizer generates hypotheses linking dysfibrinogenemia to FXIII crosslinking from Laurens et al. (2006).
Frequently Asked Questions
What defines fibrinogen's role in hemostasis?
Fibrinogen bridges activated platelets via GPIIb/IIIa receptors and polymerizes into fibrin clots stabilized by FXIII (Bennett et al., 1979).
What are key methods for studying fibrinogen?
125I-fibrinogen binding assays measure platelet receptor exposure by ADP (Bennett et al., 1979). Laurell rocket immunoassays quantify deficiencies (Griffin et al., 1981). Split product estimation diagnoses fibrinolysis (Merskey et al., 1966).
What are landmark papers?
Thompson et al. (1995, 1798 citations) links fibrinogen to infarction risk. Pepys et al. (2003, 3272 citations) details acute phase response. Bennett et al. (1979, 855 citations) shows receptor exposure.
What open problems exist?
Causal mechanisms for fibrinogen-thrombosis links remain unclear despite predictions (Thompson et al., 1995). Dysfibrinogenemia functional impacts need better in vivo models (Laurens et al., 2006).
Research Blood properties and coagulation with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Fibrinogen in Hemostasis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Blood properties and coagulation Research Guide